HIV / AIDS in the News

San Diego City Council repeals outdated bathhouse code viewed as homophobic - cbs8.com

 

Can Bixlenvo Unlock New Growth for Gilead's HIV Business? - Yahoo Finance

 

Can Bixlenvo Unlock New Growth for Gilead's HIV Business? - Zacks Investment Research

 

Is DTG/3TC Comparable to Triple Therapy in High Viral Load? - medscape.com

 

Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy - Nature

 

UNAIDS condemns the destruction of lifesaving HIV supplies in Ukraine - UNAIDS

 

Natural killers blast HIV reservoir landscape - Nature

 

Opinion - We cannot go back on Medicaid coverage for people living with HIV - Yahoo

 

We cannot go back on Medicaid coverage for people living with HIV - The Hill

 

GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit? - TradingView

 

Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV - EIN News

 

New Freddie campaign turns PrEP access in North America into HIV prevention in Africa - NOW Toronto

 

Gilead Wins Approval for a Single HIV Tablet Aimed at Patients Taking Handfuls of Pills Each Day - Medical Daily

 

Study from Lichterfeld and Yu Labs Shows HIV Reservoirs are Visible to Immune System, Challenging Longstanding Assumptions - Ragon Institute

 

HIV patient credits caseworker for lifesaving support - WTVC

 

HIV testing surges amid social media discussion - Jamaica Gleaner

 

The HIV clinics that disappeared when American aid stopped - Daily Nation

 

San Diego repeals bathhouse regulations passed amid HIV/AIDS panic - KPBS

 

Most states provide minors autonomy to consent to STI/HIV services - medicalxpress.com

 

ADAP Waiting Lists: Inhumane, Fiscally Irresponsible and Bad Policy - POZ

 

Richmond man with HIV accused of sexually abusing child - Pal-Item

 

HIV patient credits caseworker for lifesaving support - WTVC

 

A new once-daily pill to treat HIV just got the FDA’s green light - Yahoo

 

A new once-daily pill to treat HIV just got the FDA’s green light - Advocate.com

 

FDA Approves Bixlenvo for HIV-1 Switch Therapy in Virologically Suppressed Adults - patientcareonline.com

 

FDA Approves Gilead's New Single Tablet HIV Regimen - Benzinga

 

Rapid ART Boosts Early HIV Care Retention - Medscape

 

Researchers in Brazil are exploring how lenacapavir can advance HIV prevention - Unitaid

 

660 children acquired HIV every day in 2025, while 200 died from AIDS-related causes: UNICEF - Down To Earth

 

Gilead wins US nod for Bixlenvo, a new HIV combo for patients with suppressed viral load - Новости GxP